Announced
Completed
Financials
Tags
Acquisition
Biotechnology
Majority
biotechnology
Domestic
Friendly
health care
Private Equity
Privatisation
United States
Public
Completed
Synopsis
A consortium of investors, including Elliott, Patient Square and Veritas Capital, completed the acquisition of Syneos Health, a health care company, for $7.1bn. “The company has a strong operating foundation, differentiated, integrated solutions and a focus on being committed to customers. We believe this transaction will enable Syneos Health to continue to accelerate its growth strategy, enhance customer delivery and evolve the organization toward a tech-enabled future,” John Dineen, Syneos Health Chairman.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.